Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis - PubMed (original) (raw)
Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis
A O Hueber et al. Science. 1997.
Abstract
Induction of apoptosis by oncogenes like c-myc may be important in restraining the emergence of neoplasia. However, the mechanism by which c-myc induces apoptosis is unknown. CD95 (also termed Fas or APO-1) is a cell surface transmembrane receptor of the tumor necrosis factor receptor family that activates an intrinsic apoptotic suicide program in cells upon binding either its ligand CD95L or antibody. c-myc-induced apoptosis was shown to require interaction on the cell surface between CD95 and its ligand. c-Myc acts downstream of the CD95 receptor by sensitizing cells to the CD95 death signal. Moreover, IGF-I signaling and Bcl-2 suppress c-myc-induced apoptosis by also acting downstream of CD95. These findings link two apoptotic pathways previously thought to be independent and establish the dependency of Myc on CD95 signaling for its killing activity.
Comment in
- A Myc-induced apoptosis pathway surfaces.
Green DR. Green DR. Science. 1997 Nov 14;278(5341):1246-7. doi: 10.1126/science.278.5341.1246. Science. 1997. PMID: 9411752 No abstract available.
Similar articles
- Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiation.
Amanullah A, Liebermann DA, Hoffman B. Amanullah A, et al. Oncogene. 2002 Feb 28;21(10):1600-10. doi: 10.1038/sj.onc.1205231. Oncogene. 2002. PMID: 11896589 - A Myc-induced apoptosis pathway surfaces.
Green DR. Green DR. Science. 1997 Nov 14;278(5341):1246-7. doi: 10.1126/science.278.5341.1246. Science. 1997. PMID: 9411752 No abstract available. - c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release.
Juin P, Hueber AO, Littlewood T, Evan G. Juin P, et al. Genes Dev. 1999 Jun 1;13(11):1367-81. doi: 10.1101/gad.13.11.1367. Genes Dev. 1999. PMID: 10364155 Free PMC article. - Mutations in apoptosis genes: a pathogenetic factor for human disease.
Müllauer L, Gruber P, Sebinger D, Buch J, Wohlfart S, Chott A. Müllauer L, et al. Mutat Res. 2001 Jul;488(3):211-31. doi: 10.1016/s1383-5742(01)00057-6. Mutat Res. 2001. PMID: 11397650 Review. - CD95 ligand: lethal weapon against malignant glioma?
Weller M, Kleihues P, Dichgans J, Ohgaki H. Weller M, et al. Brain Pathol. 1998 Apr;8(2):285-93. doi: 10.1111/j.1750-3639.1998.tb00154.x. Brain Pathol. 1998. PMID: 9546287 Free PMC article. Review.
Cited by
- Molecular analysis of Annexin expression in cancer.
Hein T, Krammer PH, Weyd H. Hein T, et al. BMC Cancer. 2022 Sep 19;22(1):994. doi: 10.1186/s12885-022-10075-8. BMC Cancer. 2022. PMID: 36123610 Free PMC article. - The glucose-sensing transcription factor MLX balances metabolism and stress to suppress apoptosis and maintain spermatogenesis.
Carroll PA, Freie BW, Cheng PF, Kasinathan S, Gu H, Hedrich T, Dowdle JA, Venkataramani V, Ramani V, Wu X, Raftery D, Shendure J, Ayer DE, Muller CH, Eisenman RN. Carroll PA, et al. PLoS Biol. 2021 Oct 20;19(10):e3001085. doi: 10.1371/journal.pbio.3001085. eCollection 2021 Oct. PLoS Biol. 2021. PMID: 34669700 Free PMC article. - Crosstalk of the Wnt/β-Catenin Signaling Pathway in the Induction of Apoptosis on Cancer Cells.
Trejo-Solis C, Escamilla-Ramirez A, Jimenez-Farfan D, Castillo-Rodriguez RA, Flores-Najera A, Cruz-Salgado A. Trejo-Solis C, et al. Pharmaceuticals (Basel). 2021 Aug 28;14(9):871. doi: 10.3390/ph14090871. Pharmaceuticals (Basel). 2021. PMID: 34577571 Free PMC article. Review. - Tilting MYC toward cancer cell death.
Harrington CT, Sotillo E, Dang CV, Thomas-Tikhonenko A. Harrington CT, et al. Trends Cancer. 2021 Nov;7(11):982-994. doi: 10.1016/j.trecan.2021.08.002. Epub 2021 Sep 2. Trends Cancer. 2021. PMID: 34481764 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous